US · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 1.32 against a street estimate of 1.11 — a beat of 18.9%.
Analysts rate Lantheus Holdings Inc a buy (3 buy, 7 hold, 0 sell out of 10) with an average price target of $106.99.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.86% |
| Farallon Capital Management, L.L.C. | 8.55% |
| Jupiter Topco LLC | 7.95% |
| HHG PLC | 7.31% |
| FMR Inc | 5.94% |
| Vanguard Portfolio Management, LLC | 4.96% |
| Vanguard Capital Management, LLC | 4.49% |
| American Century Companies Inc | 4.31% |
| Document | Date |
|---|---|
| Shareholder vote results · Q4 2026 HEADLINE NUMBERS • Lantheus stockholders approved the proposed merger agreement with Curium US Holdings LLC. • Votes on the merger agreement: 55,457 | 2026-10-14 |
| Company announcement · Q4 2026 HEADLINE NUMBERS • Lantheus has agreed to be acquired by Curium US Holdings LLC, with the transaction requiring stockholder approval. • A special st | 2026-10-02 |
| Company announcement · Q3 2026 LANTHEUS HOLDINGS, INC. - 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Lantheus Holdings is a Delaware corporation (ticker: LNTH on Nasdaq) headquart | 2026-09-21 |
| Quarterly report · Q2 2026 LANTHEUS HOLDINGS, INC. - 10-Q SUMMARY (Q2 2026) HEADLINE NUMBERS • Q2 2026 Revenue: $388.2 million (up 2.7% vs. Q2 2025: $378.0 million) • Six-Mont | 2026-08-06 |
| Results announced · Q3 2026 LANTHEUS HOLDINGS Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Worldwide revenue: $388.2 million in Q2 2026, up 2.7% vs. $378.0 million in Q2 2025 • | 2026-08-06 |
| Material agreement · Q3 2026 LANTHEUS HOLDINGS, INC. – 8-K SUMMARY HEADLINE NUMBERS • Acquisition price: $102.50 per share in cash plus one Contingent Value Right (CVR) worth up | 2026-08-04 |
| Reg FD disclosure · Q3 2026 LANTHEUS HOLDINGS, INC. - 8-K SUMMARY HEADLINE NUMBERS • Merger Agreement executed: August 3, 2026 between Lantheus Holdings, Inc., Curium US Holdin | 2026-08-03 |
| Quarterly report · Q1 2026 LANTHEUS HOLDINGS, INC. — Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenues: $377.3 million (Q1 2026) vs. $372.8 million (Q1 2025), +1.2% growt | 2026-05-07 |
Readable in the app.
| Announcement | Date |
|---|---|
| Agreement and Plan of Merger with Curium US Holdings LLC entered into Lantheus Holdings announced that three lawsuits and sixteen demand letters have been filed by shareholders challenging a merger deal with Curium US Holdings LLC. The complaints allege that t | 2026-10-02 |
| Agreement and Plan of Merger entered into with Curium US Holdings Lantheus Holdings announced that its acquiring company, Curium US Holdings LLC, voluntarily withdrew and refiled its antitrust notification with the Federal Trade Commission (FTC) on Septemb | 2026-09-21 |
| Entered into definitive agreement to merge with Curium for $8.0 billion Lantheus Holdings reported Q2 2026 results with mixed financial performance. Revenue grew modestly 2.7% to $388.2 million versus Q2 2025, driven by a 5.2% increase in DEFINITY sales ($88.3M) | 2026-08-06 |
| Entered into merger agreement with Curium US Holdings LLC Lantheus Holdings, Inc. announced it has agreed to be acquired by Curium US Holdings LLC in an all-cash merger. Under the deal terms, Lantheus shareholders will receive $102.50 per share in | 2026-08-04 |
| Company to be acquired by Parent in proposed merger transaction Lantheus Holdings is being acquired by a parent company in a merger transaction. The company has paused its previously-announced CEO search process due to this pending acquisition. The 8-K i | 2026-08-03 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lantheus Holdings Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.